Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin [Urologic Oncology]
Conclusion
After 5 years of follow-up, pulmonary impairment in patients with germ cell cancer who were treated with BEP was limited. Exceptions were patients treated with pulmonary surgery, those who suffered pulmonary embolism, and those in the IGCCCG poor prognostic group.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Lauritsen, Kier, Bandak, Mortensen, Thomsen, Mortensen, Daugaard Tags: Chemotherapy Urologic Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carbon Monoxide Poisoning | Chemotherapy | Pulmonary Thromboembolism | Smokers | Study | Toxicology | Urology & Nephrology